Shore Capital restated their hold rating on shares of GlaxoSmithKline (LON:GSK) in a research report released on Thursday morning, Digital Look reports.
Other equities analysts have also issued research reports about the company. Kepler Capital Markets lifted their price target on GlaxoSmithKline from GBX 1,440 ($18.82) to GBX 1,540 ($20.12) and gave the company a hold rating in a research note on Tuesday, June 11th. UBS Group reiterated a neutral rating and set a GBX 1,610 ($21.04) price objective (up from GBX 1,610 ($21.04)) on shares of GlaxoSmithKline in a report on Thursday, July 25th. JPMorgan Chase & Co. started coverage on shares of GlaxoSmithKline in a report on Tuesday, August 13th. They set a neutral rating and a GBX 1,700 ($22.21) price objective on the stock. Liberum Capital reiterated a hold rating on shares of GlaxoSmithKline in a report on Tuesday, July 2nd. Finally, HSBC set a GBX 1,942 ($25.38) price objective on shares of GlaxoSmithKline and gave the stock a buy rating in a report on Tuesday, July 16th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of GBX 1,628.56 ($21.28).
Shares of GSK opened at GBX 1,691.20 ($22.10) on Thursday. GlaxoSmithKline has a 52-week low of GBX 1,408.80 ($18.41) and a 52-week high of GBX 1,749.40 ($22.86). The business’s fifty day moving average is GBX 1,663.51 and its 200-day moving average is GBX 1,580.91. The company has a debt-to-equity ratio of 1,127.74, a quick ratio of 0.44 and a current ratio of 0.71. The firm has a market cap of $84.36 billion and a price-to-earnings ratio of 19.05.
The company also recently declared a dividend, which will be paid on Thursday, October 10th. Shareholders of record on Thursday, August 8th will be issued a dividend of GBX 19 ($0.25) per share. This represents a yield of 1.13%. The ex-dividend date of this dividend is Thursday, August 8th. GlaxoSmithKline’s dividend payout ratio (DPR) is presently 0.86%.
In other news, insider Vivienne Cox purchased 434 shares of the stock in a transaction on Wednesday, July 24th. The stock was bought at an average price of GBX 1,654 ($21.61) per share, for a total transaction of £7,178.36 ($9,379.80). Insiders have acquired a total of 456 shares of company stock valued at $753,737 in the last quarter.
GlaxoSmithKline Company Profile
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare.
Featured Story: Coverage Ratio
Receive News & Ratings for GlaxoSmithKline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline and related companies with MarketBeat.com's FREE daily email newsletter.